David Efraim Rosen's Net Worth
$21.8 Million
Who is David Efraim Rosen?
David Efraim Rosen has an estimated net worth of $21.8 Million. This is based on reported shares across multiple companies, which include Vincerx Pharma, Inc., Radius Health, Inc., TherapeuticsMD, Inc., and HERON THERAPEUTICS, INC. /DE/.
SEC CIK
David Efraim Rosen's CIK is 0001898677
Past Insider Trading and Trends
2022 was David Efraim Rosen's most active year for acquiring shares with 11 total transactions. David Efraim Rosen's most active month to acquire stocks was the month of November. 2022 was David Efraim Rosen's most active year for disposing of shares, totalling 2 transactions. David Efraim Rosen's most active month to dispose stocks was the month of November. 2022 saw David Efraim Rosen paying a total of $46,620,798.89 for 2,394,784 shares, this is the most they've acquired in one year. In 2022 David Efraim Rosen cashed out on 58,000 shares for a total of $77,314,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vincerx Pharma, Inc. (VINC) Snapshot price: $1.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Radius Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.11% | 1.68M |
$10.07 | $16,907,066.78 | 8.64M |
Aug 11
| |||
Form 4
| +0.06% | 4.01K |
$10.07 | $40,400.84 | 6.96M |
Aug 10
| |||
Form 4
| +2.15% | 146.69K |
$7.07 | $1,037,752.37 | 6.96M |
Dec 16
| |||
Form 4
| +3.59% | 462.24K |
$6.93 | $3,191,375.65 | 13.35M |
Dec 13 - Dec 15
| |||
Form 4
| +15.82% | 1.59M |
$7.65 | $12,015,791.72 | 11.67M |
Dec 8 - Dec 10
| |||
| No matching records found | |||||||||
TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +42.38% | 877.19K |
$2.28 | $1,999,997.76 | 2.95M |
Nov 15
| |||
Form 4
| +17.79% | 312.52K |
$3.68 | $1,149,998.24 | 2.07M |
Jun 28
| |||
Form 4/A
| -100.00% | -29.00K |
$1,333.00 | -$38,657,000.00 |
0
|
Dec 30
| |||
Form 4
| -100.00% | -29.00K |
$1,333.00 | -$38,657,000.00 |
0
|
Dec 30
| |||
Form 4
| +0.85% | 14.82K |
$6.09 | $90,284.25 | 1.76M |
Dec 9
| |||
Form 4
| +0.59% | 20.41K |
$5.75 | $115,638.86 | 3.48M |
Dec 7 - Dec 8
| |||
Form 4
| +31.82% | 7K |
$1,000.00 | $7,000,000.00 | 29K |
Oct 28
| |||
Form 4
| +46.67% | 7K |
$1,000.00 | $7,000,000.00 | 22K |
Sep 30
| |||
Form 4
| +50.13% | 580K |
$413.47 | $14,999,950.00 | 1.74M |
Jul 29
| |||
Form 4
| +3.73% | 82.58K |
$5.80 | $467,458.16 | 2.3M |
Jul 15 - Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mereo BioPharma Group plc (MREO) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||